PHARMACOKINETIC/PHARMACODYNAMIC INTERACTIONS BETWEEN EVOGLIPTIN AND GLIMEPIRIDE IN HEALTHY MALE VOLUNTEERS.

被引：0
|
作者：
Yoo, H. [1 ]
Kim, Y. [1 ]
Sunwoo, J. [1 ]
Kim, Y. [1 ]
Lee, H. [1 ]
Jang, I. -J. [1 ]
Yu, K. -S. [1 ]
机构：
[1] SNUH, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-157
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects
    Yoo, Hyounggyoon
    Kim, Yun
    Jang, In-Jin
    Yu, Kyung-Sang
    Lee, SeungHwan
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5179 - 5187
  • [2] Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
    Kim, Dasohm
    Choi, Minkyu
    Jin, Byung Hak
    Hong, Taegon
    Kim, Choon Ok
    Yoo, Byung Won
    Park, Min Soo
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (08): : 1469 - 1478
  • [3] Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
    Hwang, Inyoung
    Kim, Yun
    Yoo, Hyounggyoon
    Jang, In-Jin
    Yu, Kyung-Sang
    Lee, SeungHwan
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 4493 - 4502
  • [4] Pharmacokinetic interactions between udenafil and ketoconazole in healthy volunteers.
    Kim, J. W.
    Kim, J. R.
    Lim, K. S.
    Kim, B. H.
    Kim, M. G.
    Chung, Y. J.
    Kim, T. E.
    Cho, J. Y.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S114 - S115
  • [5] Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions
    Khan, ZP
    Munday, IT
    Jones, RM
    Thornton, C
    Mant, TG
    Amin, D
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (03) : 372 - 380
  • [6] Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers
    Dockens, RC
    Greene, DS
    Barbhaiya, RH
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (02): : 160 - 167
  • [7] Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers
    Booker, BM
    Magee, MH
    Blum, RA
    Lates, CD
    Jusko, WJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (04) : 370 - 382
  • [8] Pharmacokinetic and pharmacodynamic profile of the CCKA antagonist tarazepide in healthy volunteers.
    de Vries, MH
    Van den Broeck, P
    UdodeHaes, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 122 - 122
  • [9] Pharmacokinetic/pharmacodynamic (PK/PD) modeling of captopril in healthy volunteers.
    Yi, SY
    Bae, KS
    Lim, HS
    Cho, JY
    Yu, KS
    Jang, IJ
    Shin, SG
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P74 - P74
  • [10] ABSENCE OF MUTUAL PHARMACOKINETIC INTERACTIONS BETWEEN CILOSTAZOL AND PROBUCOL IN HEALTHY VOLUNTEERS.
    Kim, K. P.
    Kim, B. H.
    Kim, T. E.
    Kim, C. W.
    Yu, K. S.
    Shin, S. G.
    Jang, I. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S16 - S16
12345